Completed
Safety, Tolerability and PK of BTK Inhibitor DTRMWXHS-12 in Patients With B-Cell Lymphomas
NCT02891590
- Conditions
- B-Cell Lymphomas, Chronic Disease, Chronic Lymphocytic Leukemia, +18 more
- Locations
-
- Peking University Cancer Hospital Beijing, China